The goal of this research is to develop a novel separation media technology to replace conventional polyacrylamide gels in electrophoresis. The new sieving matrices will employ pre-polymerized acrylamide-based polymers capable of thermo-reversible gelation similar to agarose. As a result, these gel matrices can be pre-formulated and supplied to users as a powder or solution that is simply heated and poured into standard horizontal and vertical electrophoresis units. By eliminating end-user involvement in the synthesis of polyacrylamide gels, significant enhancements in electrophoresis efficiency, safety and reproducibility will be achieved, while retaining the exceptional resolving power of traditional polyacrylamide. The Phase I objectives are to: (I) Develop the basic formulation requirements for optimizing gel physical properties (e.g., strength, clarity and rheology), (2) Develop specific gel formulations for use in dsDNA analysis, e.g., for PCR product analysis, mapping, etc., and (3) Develop gel formulations for mutation screening by heteroduplex and SSCP analysis. Phase II will leverage the Phase I research by extending the range of applications to include native and denaturing protein electrophoresis.

Proposed Commercial Applications

The electrophoresis matrices developed in this research will have immediate commercial utility as safe and convenient substitutes for polyacrylamide and related acrylamide-based gels. By eliminating the labor-intensive and often unreliable preparation of polyacrylamide gels starting from toxic monomers, the new matrices will provide important benefits to end-users.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
7R43GM052242-02
Application #
2191196
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (09))
Project Start
1995-01-01
Project End
1995-06-30
Budget Start
1995-04-16
Budget End
1995-06-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Aclara Biosciences, Inc.
Department
Type
DUNS #
City
Mountain View
State
CA
Country
United States
Zip Code
94043
Sassi, A P; Barron, A; Alonso-Amigo, M G et al. (1996) Electrophoresis of DNA in novel thermoreversible matrices. Electrophoresis 17:1460-9